New on Particle

Political Spectrum Ratings on Individual Articles

Particle.news

Business ❯Pharmaceutical Industry

Pfizer

Marketing Practices BioNTech Acquisitions Contracts Revenue Sales COVID-19 Vaccine Financial Performance COVID-19 Products CEO Albert Bourla Albert Bourla Financial Outlook Quarterly Losses COVID-19 Treatment Clinical Trials

Kansas Sues Pfizer Over Misleading COVID-19 Vaccine Claims

Pfizer's Lorbrena Sets New Benchmark in Treating Advanced Lung Cancer

Pfizer Shares Hit 10-Year Low Amid Decreased Demand for COVID-19 Products

Pfizer Posts $2.38 Billion Q3 Loss Amid Sharp Drop in Covid Vaccine and Paxlovid Revenue

Terms of Service Privacy Policy Jobs Help Partners Investors

Copyright © 2025 Mina Labs Inc.